Khanna, S., Yoho, D., Handel, D. V., Clark, B. J., Awad, T., Guthmueller, B., . . . Feuerstadt, P. Safety and effectiveness of fecal microbiota, live-jslm (REBYOTA) administered by colonoscopy for prevention of recurrent infection: 8-week results from CDI-SCOPE, a single-arm, phase IIIb trial. SAGE Publishing.
Chicago Style (17th ed.) CitationKhanna, Sahil, et al. Safety and Effectiveness of Fecal Microbiota, Live-jslm (REBYOTA) Administered by Colonoscopy for Prevention of Recurrent Infection: 8-week Results from CDI-SCOPE, a Single-arm, Phase IIIb Trial. SAGE Publishing.
MLA (9th ed.) CitationKhanna, Sahil, et al. Safety and Effectiveness of Fecal Microbiota, Live-jslm (REBYOTA) Administered by Colonoscopy for Prevention of Recurrent Infection: 8-week Results from CDI-SCOPE, a Single-arm, Phase IIIb Trial. SAGE Publishing.